SEC Form EFFECT filed by Aligos Therapeutics Inc.
$ALGS
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | April 3, 2025 4:00 P.M. |
Form: | S-3 | ||||||
|